TCTMD

Subcutaneous ICD Holds Up Well Against Transvenous Devices

In a typical population of patients requiring implantable cardioverter-defibrillator (ICD) therapy without pacing, mostly for the primary prevention of sudden cardiac death, a subcutaneous ICD (S-ICD; ...
Healio

FDA designates recall of ICD, CRT devices as class I

Please provide your email address to receive an email when new articles are posted on . The FDA announced Medtronic has issued a recall of its implantable cardioverter defibrillators and cardiac ...
Healio

Medtronic recall of ICD, CRT-D devices designated class I

Please provide your email address to receive an email when new articles are posted on . Medtronic recalled ICDs and CRT-Ds with a glassed feedthrough made after Oct. 13, 2017 due to risk for low- or ...
EurekAlert!

Disparity in use of implantable devices to prevent sudden death in heart failure patients

A study of heart failure patients who meet national guidelines for devices that stabilize and strengthen the heart's electrical system found that only half of eligible patients received the devices.
TCTMD

Subcutaneous ICD Has Favorable Outcomes in Older Patients

For older patients without an indication for pacing, the subcutaneous implantable cardioverter-defibrillator (S-ICD; Boston Scientific) provides results comparable to those seen with traditional ...
Medscape

Integra-D Shows Positive Postimplant Performance of Novel ICD, Cardiac Contractility Device

MINNEAPOLIS — Switching candidates for implantable cardioverter-defibrillator (ICD) implantation to a dual-function device that also modulates cardiac contractility was associated with successful ...
Medscape

Shorting Problem with Guidant ICD Device Causes Stir in EP Community

May 27, 2005-- Guidant Corporation (Indianapolis, Indiana) sent a letter to physicians this week informing them about a potential shorting defect in certain models of the company's PRIZM 2 DR ...
The American Journal of Managed Care

Race and Sex Differences Seen in ICD Use for Hypertrophic Cardiomyopathy

Analysis results revealed racial and sex disparities among patients with hypertrophic cardiomyopathy who receive implantable cardioverter-defibrillator (ICD) devices. Among patients hospitalized with ...